Clinical trial
Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit…
NCT00223561 · Utrecht Institute for Pharmaceutical Sciences, Other · Completed
Key facts
| NCT number | NCT00223561 |
|---|---|
| Title | Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder |
| Official title | A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder |
| Lead sponsor | Utrecht Institute for Pharmaceutical Sciences, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | methylphenidate |
| Enrollment | 18 |
| Start date | Feb 1, 2003 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 1, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: